Clinical Trials · NCT03916640
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Adocia
- Enrollment
- 24
- Start date
- Jan 2019
- Locations
- 1 site, Germany
- Primary endpoint
- CmaxPram